PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $174,000 | +37.0% | 52,170 | +44.9% | 0.00% | 0.0% |
| Q4 2015 | $127,000 | -89.7% | 35,995 | -85.4% | 0.00% | -83.3% |
| Q3 2015 | $1,239,000 | -34.5% | 246,328 | -16.2% | 0.01% | -25.0% |
| Q2 2015 | $1,891,000 | +16.8% | 294,044 | +27.8% | 0.01% | +14.3% |
| Q1 2015 | $1,619,000 | -38.7% | 230,128 | -32.8% | 0.01% | -30.0% |
| Q4 2014 | $2,639,000 | +8.8% | 342,264 | +5.4% | 0.01% | +11.1% |
| Q3 2014 | $2,425,000 | -15.0% | 324,611 | +10.1% | 0.01% | -10.0% |
| Q2 2014 | $2,853,000 | +23.8% | 294,727 | +6.3% | 0.01% | +11.1% |
| Q1 2014 | $2,304,000 | +28.6% | 277,268 | +30.6% | 0.01% | +28.6% |
| Q4 2013 | $1,792,000 | +34.6% | 212,338 | +27.2% | 0.01% | +16.7% |
| Q3 2013 | $1,331,000 | +26.5% | 166,989 | +22.6% | 0.01% | +20.0% |
| Q2 2013 | $1,052,000 | – | 136,249 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |